A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Authors
Keywords
-
Journal
Nutrients
Volume 11, Issue 1, Pages 188
Publisher
MDPI AG
Online
2019-01-18
DOI
10.3390/nu11010188
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial
- (2018) Christian Trummer et al. EUROPEAN JOURNAL OF NUTRITION
- An update on the safety of nutraceuticals and effects on lipid parameters
- (2018) Arrigo F. G. Cicero et al. Expert Opinion On Drug Safety
- Polycystic Ovary Syndrome
- (2018) Ricardo Azziz OBSTETRICS AND GYNECOLOGY
- Treatment of non-alcoholic steatohepatitis patients with vitamin D: a double-blinded, randomized, placebo-controlled pilot study
- (2018) Andreas Geier et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The Role of Vitamin D Oral Supplementation in Insulin Resistance in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2018) Karolina Łagowska et al. Nutrients
- The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial
- (2017) Maryam Seyyed Abootorabi et al. GYNECOLOGICAL ENDOCRINOLOGY
- The effect of Vitamin D supplementation on hormonal and glycaemic profile of patients with PCOS: A meta-analysis of randomised trials
- (2017) Vasilios Pergialiotis et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
- (2017) J Cai et al. INTERNATIONAL JOURNAL OF OBESITY
- Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation
- (2017) Jaividhya Dasarathy et al. JOURNAL OF NUTRITION
- 1,25(OH)2 D3 attenuates hepatic steatosis by inducing autophagy in mice
- (2017) Renlong Li et al. Obesity
- Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome
- (2017) Mehri Jamilian et al. Nutrients
- Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis
- (2016) Yunping Xue et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) et al. DIABETOLOGIA
- Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome
- (2016) D. Macut et al. HUMAN REPRODUCTION
- Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome
- (2015) Zatollah Asemi et al. CLINICAL NUTRITION
- Vitamin D Supplementation Decreases TGF-β1 Bioavailability in PCOS: A Randomized Placebo-Controlled Trial
- (2015) Mohamad Irani et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Vitamin D: A new player in non-alcoholic fatty liver disease?
- (2015) Myrto Eliades WORLD JOURNAL OF GASTROENTEROLOGY
- Serum Vitamin D Levels and Polycystic Ovary syndrome: A Systematic Review and Meta-Analysis
- (2015) Chunla He et al. Nutrients
- Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study
- (2015) G. Garg et al. Endocrine Connections
- National Osteoporosis Society Vitamin D Guideline Summary
- (2014) T. J. Aspray et al. AGE AND AGEING
- High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial
- (2014) Nazia Raja-Khan et al. FERTILITY AND STERILITY
- Vitamin D modulates biliary fibrosis in ABCB4-deficient mice
- (2014) Katrin Hochrath et al. Hepatology International
- A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response
- (2013) Ning Ding et al. CELL
- The Enhanced Liver Fibrosis (ELF) score: Normal values, influence factors and proposed cut-off values
- (2013) Ralf Lichtinghagen et al. JOURNAL OF HEPATOLOGY
- 1,25-dihydroxyvitamin D3 and its nuclear receptor repress human α1(I) collagen expression and type I collagen formation
- (2013) James J. Potter et al. LIVER INTERNATIONAL
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association
- (2012) Naga Chalasani et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Low levels of 25(OH)D and insulin-resistance: 2 unrelated features or a cause-effect in PCOS?
- (2012) Giovanna Muscogiuri et al. CLINICAL NUTRITION
- Therapeutic implications of vitamin D and calcium in overweight women with polycystic ovary syndrome
- (2012) Lubna Pal et al. GYNECOLOGICAL ENDOCRINOLOGY
- Prospective Validation of ELF Test in Comparison with Fibroscan and FibroTest to Predict Liver Fibrosis in Asian Subjects with Chronic Hepatitis B
- (2012) Beom Kyung Kim et al. PLoS One
- Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
- (2011) S. Abramovitch et al. GUT
- Atorvastatin Increases 25-Hydroxy Vitamin D Concentrations in Patients with Polycystic Ovary Syndrome
- (2010) T. Sathyapalan et al. CLINICAL CHEMISTRY
- The ELF panel: a new crystal ball in hepatology?
- (2010) M. Pinzani GUT
- Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
- (2010) J. Parkes et al. GUT
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- (2010) Robert A. Wild et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats
- (2010) Toshiaki Nakano et al. JOURNAL OF HEPATOLOGY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started